10 Atrial Fibrillation Clinical Trials in Miami, TX (2026)

Q: How do I join a clinical trial in Miami?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you.

Recruiting Atrial Fibrillation Studies in Miami

NCT06953726Recruiting

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

* The trial will compare two anticoagulants ("blood thinners") that are currently used in the VA and are considered standard care to prevent strokes in patients with atrial fibrillation. The two most ...

Miami, TX10,000 participantsVA Office of Research and Development

View Study Details

NCT06876649Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

Miami, TX787 participantsEli Lilly and Company

View Study Details

NCT06735534Recruiting

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters....

Miami, TX376 participantsBoston Scientific Corporation

View Study Details

NCT04710576Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

This is a Phase 2 study to evaluate the efficacy, safety, and tolerability of axatilimab at 3 different dose levels in participants with recurrent or refractory active chronic graft versus host diseas...

Miami, TX296 participantsSyndax Pharmaceuticals

View Study Details

NCT07227532Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with s...

Miami, TX276 participantsBiosense Webster, Inc.

View Study Details

NCT06585774Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

This study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGV...

Miami, TX240 participantsIncyte Corporation

View Study Details

NCT07111663Recruiting

An Observational Study of Individuals With Isolated Dystonia

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your phys...

Miami, TX200 participantsVima Therapeutics

View Study Details

NCT06660355Recruiting

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Allogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has ...

Miami, TX120 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT05531786Recruiting

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Background: Chronic graft-versus-host disease (cGVHD) is an immune system disorder that can occur in people who have had a stem cell transplant. cGVHD can affect multiple organs and increase risk of ...

Miami, TX50 participantsNational Cancer Institute (NCI)

View Study Details

NCT06663722Recruiting

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

The purpose of this study is to see whether giving participants a combination treatment of Axatilimab and Extracorporeal Photopheresis (ECP) is effective against chronic Graft-versus-Host Disease (cGV...

Miami, TX49 participantsUniversity of Miami

View Study Details

About Atrial Fibrillation Clinical Trials in Miami

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 10 atrial fibrillation clinical trials recruiting participants in Miami, TX. These studies are seeking a combined 12,394 participants. Research is being sponsored by VA Office of Research and Development, Eli Lilly and Company, Boston Scientific Corporation and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Miami — FAQ

Are there atrial fibrillation clinical trials in Miami?

Yes, there are 10 atrial fibrillation clinical trials currently recruiting in Miami, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 10 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 13, 2026 from ClinicalTrials.gov